The past and present of aging biotech

If you want to know where you are going, it can help to turn around and see where you have been. On June 30, Arda CEO Adam Freund will be chatting with colleagues James Peyer, PhD and Kristen Fortney about the history of the longevity biotech industry and how we got to where we are today.

Pathways to Impact is a virtual event series organized by Norn Group to help people who have or want careers in longevity better design their career paths. Events are virtual, so anyone anywhere can join! https://norn.group/pathways-home

Recording of the panel here

Previous
Previous

Arda presents at 7th Annual Antifibrotics Drug Development Conference

Next
Next

Adam Freund participates in Longevity Debates